Filter

31 - 40 of 94 Results

  • How Much Global Health Funding Goes Through USAID?

    Policy Watch

    This analysis highlights USAID's role in global health and shows that the agency provided the vast majority of the nation's global health assistance for other countries in 2023 (about $6.2 billion or 73% of the total bilateral global health funding that year).

  • COVID-19 & PEPFAR: Implications for the Future

    Issue Brief

    The potential for the COVID-19 pandemic to significantly affect the health and development of low- and middle-income countries (LMICs), particularly those in sub-Saharan Africa, has serious implications for PEPFAR, the President’s Emergency Plan for AIDS Relief (PEPFAR). This issue brief examines the steps PEPFAR has taken to respond to the outbreak and the issues at stake.

  • The Helms Amendment and Abortion Laws in Countries Receiving U.S. Global Health Assistance

    Issue Brief

    This brief examines abortion laws in countries that received certain U.S. foreign assistance to better understand the implications of the Helms Amendment (which prohibits the use of foreign assistance to pay for the performance of abortion as a method of family planning or to motivate or coerce any person to practice abortion) for abortion access globally.

  • Assessing PEPFAR’s Impact: Analysis of Mortality in PEPFAR Countries

    Issue Brief

    As the PEPFAR program approaches its two-decade mark, this new analysis finds the program was associated with large declines in mortality in PEPFAR recipient countries since its creation in 2003, suggesting that future investments will continue to yield significant health impacts.

  • Funding for Key HIV Commodities in PEPFAR Countries

    Issue Brief

    In many low- and middle-income countries, PEPFAR and the Global Fund are significant funders of commodities to diagnose, treat, and prevent HIV, along with country governments. But, information on their relative contributions, which is important for assessing the HIV response, is not readily available. We analyzed data from PEPFAR documents on funding for key HIV commodities in 34 PEPFAR countries to better understand the funding landscape.